Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
Director departure
CC transcript
PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2012 4 SMITH JOSEPH E (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Disposed/sold 70,000 shares @ $50, valued at $3.5M
Disposed/sold 29,845 options to buy @ $50, valued at $1.5M
Disposed/sold 32,590 restricted stock units @ $50, valued at $1.6M
Disposed/sold 5,000 options to buy @ $41.6, valued at $208k
Disposed/sold 5,000 options to buy @ $42.14, valued at $210.7k
Disposed/sold 5,000 options to buy @ $33.62, valued at $168.1k
Disposed/sold 5,000 options to buy @ $26.38, valued at $131.9k
10/02/2012 4 KNIGHT PETER S (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Disposed/sold 3,500 shares @ $50, valued at $175k
Disposed/sold 22,782 options to buy @ $50, valued at $1.1M
Disposed/sold 30,090 restricted stock units @ $50, valued at $1.5M
Disposed/sold 10,000 options to buy @ $31.7, valued at $317k
Disposed/sold 10,000 options to buy @ $48.75, valued at $487.5k
Disposed/sold 5,000 options to buy @ $42.14, valued at $210.7k
Disposed/sold 5,000 options to buy @ $33.62, valued at $168.1k
Disposed/sold 5,000 options to buy @ $26.38, valued at $131.9k
10/02/2012 4 NORDMANN RONALD M (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Disposed/sold 4,000 shares @ $50, valued at $200k
Disposed/sold 1,980 options to buy @ $50, valued at $99k
Disposed/sold 30,090 restricted stock units @ $50, valued at $1.5M
Disposed/sold 10,000 options to buy @ $31.7, valued at $317k
Disposed/sold 10,000 options to buy @ $48.75, valued at $487.5k
Disposed/sold 5,000 options to buy @ $42.14, valued at $210.7k
Disposed/sold 5,000 options to buy @ $33.62, valued at $168.1k
Disposed/sold 5,000 options to buy @ $26.38, valued at $131.9k
10/02/2012 4 RICE THOMAS P (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Disposed/sold 17,339 restricted stock units @ $50, valued at $867k
10/02/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
10/02/2012 4 SHAROKY MELVIN MD (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Disposed/sold 15,201 options to buy @ $50, valued at $760.1k
Disposed/sold 25,090 restricted stock units @ $50, valued at $1.3M
Disposed/sold 5,000 options to buy @ $24.72, valued at $123.6k
10/02/2012 4 LEPORE PATRICK G (Executive Chairman) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Disposed/sold 126,792 shares @ $50, valued at $6.3M
Disposed/sold 65,000 shares @ $50, valued at $3.3M
Disposed/sold 15,000 shares @ $50, valued at $750k
Disposed/sold 8,000 shares @ $50, valued at $400k
Disposed/sold 15,000 shares @ $50, valued at $750k
Disposed/sold 50,629 restricted stock units @ $50, valued at $2.5M
Disposed/sold 2,500 restricted stock units @ $50, valued at $125k
Disposed/sold 5,000 options to buy @ $22.2, valued at $111k
Disposed/sold 120,000 options to buy @ $19.26, valued at $2.3M
Disposed/sold 11,200 options to buy @ $24.27, valued at $271.8k
Disposed/sold 120,000 options to buy @ $20, valued at $2.4M
10/02/2012 4 Tropiano Michael A (EVP and Chief Financial Office) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Disposed/sold 57,250 shares @ $50, valued at $2.9M
Disposed/sold 30,000 options to buy @ $24.29, valued at $728.7k
Disposed/sold 875 options to buy @ $33.62, valued at $29.4k
Disposed/sold 4,700 options to buy @ $24.27, valued at $114.1k
Disposed/sold 20,100 options to buy @ $13.06, valued at $262.5k
Disposed/sold 2,095 options to buy @ $27.71, valued at $58.1k
Disposed/sold 6,025 options to buy @ $27.71, valued at $167k
Disposed/sold 16,420 options to buy @ $36.54, valued at $600k
Disposed/sold 22,894 options to buy @ $32.76, valued at $750k
10/02/2012 4 HAUGHEY THOMAS (President) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Disposed/sold 69,648 shares @ $50, valued at $3.5M
Disposed/sold 900 shares @ $50, valued at $45k
Disposed/sold 25,438 rights @ $50, valued at $1.3M
Disposed/sold 25,438 restricted stock units @ $50, valued at $1.3M
Disposed/sold 14,951 options to buy @ $42.14, valued at $630k
Disposed/sold 7,496 options to buy @ $33.62, valued at $252k
Disposed/sold 13,200 options to buy @ $24.27, valued at $320.4k
Disposed/sold 34,290 options to buy @ $10.99, valued at $376.8k
Disposed/sold 44,926 options to buy @ $13.06, valued at $586.7k
Disposed/sold 8,673 options to buy @ $13.06, valued at $113.3k
Disposed/sold 25,262 options to buy @ $27.71, valued at $700k
10/02/2012 4 Campanelli Paul (CEO) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Disposed/sold 46,017 shares @ $50, valued at $2.3M
Disposed/sold 25,438 rights @ $50, valued at $1.3M
Disposed/sold 25,438 restricted stock units @ $50, valued at $1.3M
Disposed/sold 8,970 options to buy @ $42.14, valued at $378k
Disposed/sold 4,497 options to buy @ $33.62, valued at $151.2k
Disposed/sold 3,175 options to buy @ $24.27, valued at $77.1k
Disposed/sold 34,290 options to buy @ $10.99, valued at $376.8k
Disposed/sold 22,771 options to buy @ $13.06, valued at $297.4k
Disposed/sold 27,000 options to buy @ $13.06, valued at $352.6k
Disposed/sold 17,593 options to buy @ $27.71, valued at $487.5k
Disposed/sold 17,789 options to buy @ $36.54, valued at $650k
07/24/2012 4 Tropiano Michael A (Executive Vice President & CFO) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Paid exercise price by delivering 624 shares @ $50.19, valued at $31.3k
07/05/2012 4 NORDMANN RONALD M (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Granted 651 options to buy @ $36.5, valued at $23.8k
07/05/2012 4 KNIGHT PETER S (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Granted 583 options to buy @ $36.5, valued at $21.3k
07/05/2012 4 SMITH JOSEPH E (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Granted 857 options to buy @ $36.5, valued at $31.3k
07/05/2012 4 SHAROKY MELVIN MD (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Granted 617 options to buy @ $36.5, valued at $22.5k
05/17/2012 4 Tropiano Michael A (EVP and CFO) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Paid exercise price by delivering 903 shares @ $40.34, valued at $36.4k
04/04/2012 4 NORDMANN RONALD M (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Granted 597 options to buy @ $39.8, valued at $23.8k
04/04/2012 4 KNIGHT PETER S (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Granted 534 options to buy @ $39.8, valued at $21.3k
04/04/2012 4 SHAROKY MELVIN MD (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Granted 566 options to buy @ $39.8, valued at $22.5k
04/04/2012 4 SMITH JOSEPH E (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Granted 786 options to buy @ $39.8, valued at $31.3k
03/21/2012 4 KNIGHT PETER S (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Sold 3,500 shares @ $37.01, valued at $129.5k
Sold 800 shares @ $37.011, valued at $29.6k
Sold 600 shares @ $37.02, valued at $22.2k
Sold 500 shares @ $37.03, valued at $18.5k
Sold 100 shares @ $37.0306, valued at $3.7k
Sold 700 shares @ $37.05, valued at $25.9k
Sold 1,300 shares @ $37.051, valued at $48.2k
Exercised 7,500 options to buy @ $28.79, valued at $215.9k
03/21/2012 4 NORDMANN RONALD M (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Sold 2,940 shares @ $37.0119, valued at $108.8k
Sold 507 shares @ $37.02, valued at $18.8k
Sold 207 shares @ $37.03, valued at $7.7k
Sold 1,803 shares @ $37.04, valued at $66.8k
Sold 1,203 shares @ $37.05, valued at $44.6k
Sold 304 shares @ $37.06, valued at $11.3k
Sold 300 shares @ $37.07, valued at $11.1k
Sold 136 shares @ $37.08, valued at $5k
Sold 100 shares @ $37.09, valued at $3.7k
Exercised 7,500 options to buy @ $28.79, valued at $215.9k
01/13/2012 4 Tropiano Michael A (EVP and CFO) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Paid exercise price by delivering 482 shares @ $35.65, valued at $17.2k
01/13/2012 4 HAUGHEY THOMAS (President) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Paid exercise price by delivering 1,017 shares @ $35.65, valued at $36.3k
01/13/2012 4 LEPORE PATRICK G (Chairman and CEO) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Paid exercise price by delivering 1,652 shares @ $35.65, valued at $58.9k
01/13/2012 4 Campanelli Paul (COO) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Paid exercise price by delivering 1,102 shares @ $35.65, valued at $39.3k
01/11/2012 4 LEPORE PATRICK G (Chairman and CEO) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Paid exercise price by delivering 5,365 shares @ $35.09, valued at $188.3k
01/11/2012 4 Tropiano Michael A (EVP and CFO) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Paid exercise price by delivering 481 shares @ $35.09, valued at $16.9k
01/10/2012 4 SHAROKY MELVIN MD (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Granted 3,816 restricted stock units @ $0
01/09/2012 4 Campanelli Paul (COO) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Paid exercise price by delivering 806 shares @ $34.01, valued at $27.4k
Granted 25,438 options to buy @ $0
Granted 50,875 options to buy @ $32.76, valued at $1.7M
01/09/2012 4 HAUGHEY THOMAS (President) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Paid exercise price by delivering 744 shares @ $34.01, valued at $25.3k
Granted 25,438 options to buy @ $0
Granted 50,875 options to buy @ $32.76, valued at $1.7M
01/09/2012 4 Tropiano Michael A (EVP & CFO) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Granted 11,447 shares @ $0
Paid exercise price by delivering 687 shares @ $34.01, valued at $23.4k
Granted 22,894 options to buy @ $32.76, valued at $750k
01/09/2012 4 KNIGHT PETER S (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Granted 3,816 restricted stock units @ $0
01/09/2012 4 NORDMANN RONALD M (Director) has filed a Form 4 on PAR PHARMACEUTICAL COMPANIES, INC.
Txns: Granted 3,816 restricted stock units @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy